Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Sommerstein, Rami

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? [electronic resource] - Journal of the American Heart Association 04 2020 - e016509 p. digital

Publication Type: Journal Article

2047-9980

10.1161/JAHA.120.016509 doi


Angiotensin Receptor Antagonists--adverse effects
Angiotensin-Converting Enzyme 2
Angiotensin-Converting Enzyme Inhibitors--adverse effects
Betacoronavirus--drug effects
COVID-19
Cardiovascular Diseases--complications
Comorbidity
Coronavirus Infections--complications
Disease Notification
Humans
Pandemics
Peptidyl-Dipeptidase A--drug effects
Pneumonia, Viral--complications
Risk Factors
SARS-CoV-2
Severity of Illness Index